Search Results - "FOSTER, Jovonne K"

Random Plasma Glucose in Serendipitous Screening for Glucose Intolerance: Screening for Impaired Glucose Tolerance Study 2 by Ziemer, David C., Kolm, Paul, Foster, Jovonne K., Weintraub, William S., Vaccarino, Viola, Rhee, Mary K., Varughese, Rincy M., Tsui, Circe W., Koch, David D., Twombly, Jennifer G., Venkat Narayan, K. M., Phillips, Lawrence S.

“…Background With positive results from diabetes prevention studies, there is interest in convenient ways to incorporate screening for glucose intolerance into…”
Get full text

NailQoL: a quality‐of‐life instrument for onychomycosis by Warshaw, Erin M., Foster, Jovonne K., Cham, Peter M. H., Grill, Joseph P., Chen, Suephy C.

“…Background  The disease burden onychomycosis is not trivial. The aim is to develop a quality of life instrument to measure the onychomycosis burden. Methods …”
Get full text

Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis (CREST) trial by Zhang, Zefeng, Foster, Jovonne K., Kolm, Paul, Jurkovitz, Claudine T., Parker, Karen M., Murrah, Nancy V., Anderson, Grant T., Douglas, John S., Weintraub, William S.

“…The CREST trial demonstrated that after successful coronary stent implantation, the 6-month rate of target vessel revascularization (TVR) was similar (15.4% vs…”
Get full text

Baseline Quality of Life and Anxiety in Solid Organ Transplant Recipients: A Pilot Study by O'REILLY, FIONA, TRAYWICK, CARMEN, PENNIE, MICHELLE L., FOSTER, JOVONNE K., CHEN, SUEPHY C.

“…BACKGROUND Solid organ transplant recipients on high doses of immunosuppression are at increased risk for the development of nonmelanoma skin cancer (NMSC)…”
Get full text

All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl : The screening for impaired glucose tolerance study 1 (SIGT 1) by PHILLIPS, Lawrence S, WEINTRAUB, William S, ZIEMER, David C, KOLM, Paul, FOSTER, Jovonne K, VACCARINO, Viola, RHEE, Mary K, BUDHWANI, Rahim K, CAUDLE, Jane M

“…The dramatic increase in incidence of diabetes (1) has prompted efforts to identify individuals who have milder glucose intolerance, because early management…”
Get full text

Naildex: pilot evaluation of an onychodystrophy severity instrument by Warshaw, Erin M, Traywick, Carmen A, Hoffman, Allison A, Lilly, Kia K, Koshnick, Rebecca L, Robinson, Janet W, Suwattee, Pitiporn, Foster, Jovonne K, Chen, Suephy C

“…A valid and reliable measure that captures onychodystrophy disease severity is important for both clinical and research applications. Three hundred and…”
Get full text

Digital image analysis: a reliable tool in the quantitative evaluation of cutaneous lesions and beyond by Pressley, Zakiya M, Foster, Jovonne K, Kolm, Paul, Zhao, Liping, Warren, Felicia, Weintraub, William, Sumpio, Bauer E, Chen, Suephy C

Get more information

Baseline Quality of Life and Anxiety in Solid Organ Transplant Recipients: A Pilot Study by OʼREILLY, FIONA, TRAYWICK, CARMEN, PENNIE, MICHELLE L., FOSTER, JOVONNE K., CHEN, SUEPHY C.

Get full text

All Pre-Diabetes Is Not the Same: Metabolic and Vascular Risks of Impaired Fasting Glucose at 100 Versus 110 mg/dl by Phillips, Lawrence S., Weintraub, William S., Ziemer, David C., Kolm, Paul, Foster, Jovonne K., Vaccarino, Viola, Rhee, Mary K., Budhwani, Rahim K., Caudle, Jane M.

Get full text

NailQoL: a quality-of-life instrument for onychomycosis by Warshaw, Erin M., Foster, Jovonne K., Cham, Peter M. H., Grill, Joseph P., Chen, Suephy C.

Get full text